Does GOLIMUMAB Cause Product dose omission? 732 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 732 reports of Product dose omission have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 1.1% of all adverse event reports for GOLIMUMAB.
732
Reports of Product dose omission with GOLIMUMAB
1.1%
of all GOLIMUMAB reports
4
Deaths
58
Hospitalizations
How Dangerous Is Product dose omission From GOLIMUMAB?
Of the 732 reports, 4 (0.5%) resulted in death, 58 (7.9%) required hospitalization.
Is Product dose omission Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 732 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Product dose omission?
APREMILAST (4,567)
DUPILUMAB (2,729)
ALBUTEROL (1,742)
USTEKINUMAB (1,653)
INSULIN GLARGINE (1,500)
ETANERCEPT (1,400)
LENALIDOMIDE (1,400)
RUXOLITINIB (1,376)
ALIROCUMAB (1,354)
DIMETHYL (1,248)
Which GOLIMUMAB Alternatives Have Lower Product dose omission Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN